Rbc Life Sciences, Inc. - Current report filing (8-K)
November 06 2007 - 11:47AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest
event reported): November 5, 2007
RBC Life Sciences,
Inc.
(Exact name of registrant as
specified in its charter)
|
|
|
|
|
NEVADA
|
|
000-50417
|
|
91-2015186
|
(State or other Jurisdiction of Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
|
|
|
2301 CROWN COURT, IRVING,
TEXAS
|
|
75038
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Registrant’s telephone number,
including area code:
972-893-4000
|
N/A
|
(Former name or former address if changed since last report.)
|
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
1
Item 2.02 Results of
Operations and Financial Condition
.
On November 5, 2007, RBC Life
Sciences, Inc. issued a press release announcing its financial results for the
quarter ended September 30, 2007. A copy of the press release is being
furnished as Exhibit 99.1 to this Form 8-K.
In accordance with General
Instruction B.2 of Form 8-K, this information, including the exhibit related
hereto, shall not be deemed “filed” for purposes of Section 18
of the Securities Exchange Act of 1934, as amended, nor shall it be deemed
incorporated by reference in any disclosure document of the Company, except as
shall be expressly set forth by specific reference in such document.
Item 9.01 Financial
Statements and Exhibits.
(d) Exhibits
|
|
|
Exhibit
No.
|
|
Description
|
99.1
|
|
Press release dated November 5, 2007
announcing financial results for the quarter ended September 30, 2007.
|
-2-
2
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly authorized.
Date: November 6, 2007
RBC Life Sciences,
Inc.
By:
/
s/
Steven E.
Brown
Name:
Steven E. Brown
Title: Chief Financial Officer
-3-
3
Exhibit Index
|
|
|
Exhibit
Number
|
|
Description
|
99.1
|
|
Press release dated November 5, 2007
announcing financial results for the quarter ended September 30, 2007
|
4
RBC Life Sciences (CE) (USOTC:RBCL)
Historical Stock Chart
From Jun 2024 to Jul 2024
RBC Life Sciences (CE) (USOTC:RBCL)
Historical Stock Chart
From Jul 2023 to Jul 2024